Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [55]
In the citing paper
“most clinically effective antipsychotics also exhibit a myriad of other actions that contribute to both therapeutic and side-effect profiles [359,360].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [360]
In the citing paper
“This often generates beneficial therapeutic activities,102 due to additive or synergistic pharmacological effects.103”
From QSAR without borders (2020) · cites this paper as [102]
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationBurris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033175 · Cited by 922
Research works printed but not linked: 1
- Hemrick–Luecke, S. et al. Pharmacological activity of aripiprazole at presynaptic and postsynaptic dopamine receptors and in antipsychotic models. Proc. Soc. Neurosci. 894.9 (2002).
Cited by
Items 701–800 of 1,000
Biological Networks and Drug Discovery—Where Do We Stand?
Geppert, T., & Koeppen, H. (2014) · Drug Development Research · doi:10.1002/ddr.21207 · Cited by 16
The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI
Cushnie, A. K., Bullock, D. N., Manea, A. M. G., Tang, W., Zimmermann, J., & Heilbronner, S. R. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100072 · Cited by 14
Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors
Erzengin, M., Bilen, Ç., Ergün, A., & Gençer, N. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.863359 · Cited by 14
Carro, L., Torrado, M. C., Raviña, E., Masaguer, C. F., Lage, S., Brea, J. M., & Loza, M. I. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.066 · Cited by 14
Park, K., Lee, S., Ahn, H., & Kim, D. (2009) · Molecular BioSystems · doi:10.1039/b901356c · Cited by 14
Carro, L., Raviña, E., Domínguez, E., Brea, J. M., Loza, M. I., & Masaguer, C. F. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.041 · Cited by 14
Structural motifs recurring in different folds recognize the same ligand fragments
Ausiello, G., Gherardini, P. F., Gatti, E., Incani, O., & Helmer‐Citterich, M. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-182 · Cited by 14
Canuso, C. M., & Battisti, W. P. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.495387 · Cited by 14
Studying human disease using human neurons
Ahfeldt, T., Litterman, N. K., & Rubin, L. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.051 · Cited by 18
Wu, S. ‐., Yu, H., Jiang, T. ‐., Gao, C. ‐., & Shen, J. ‐. (2015) · Insect Molecular Biology · doi:10.1111/imb.12171 · Cited by 15
Fishing for neuroactive compounds
Jenkins, J. L., & Urbán, L. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.320 · Cited by 14
Roth, B. L. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/broth · Cited by 16
Self-citationM1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study
Fu, L., Luo, Y., Niu, L., Lin, Y., Chen, X., Zhang, J., Tang, W., Chen, Y., & Jiao, Y. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117728 · Cited by 13
Giorgioni, G., Bonifazi, A., Botticelli, L., Cifani, C., Matteucci, F., Bonaventura, E. M. D., Bonaventura, M. V. M. D., Giannella, M., Piergentili, A., Piergentili, A., et al. (2024) · Medicinal Research Reviews · doi:10.1002/med.22049 · Cited by 13
Current development in sulfonamide derivatives to enable CNS-drug discovery
Blicharz-Futera, K., Kamiński, M., Grychowska, K., Canale, V., & Zajdel, P. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108076 · Cited by 13
Selvam, B., Porter, S. L., & Tikhonova, I. G. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400282q · Cited by 13
Functional diversification and exaptation: the emergence of new drug uses in the pharma industry
Andriani, P., & Cattani, G. (2022) · Industrial and Corporate Change · doi:10.1093/icc/dtac023 · Cited by 14
Multi-target action of β-alanine protects cerebellar tissue from ischemic damage
Kopach, O., Rusakov, D. A., & Sylantyev, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05159-z · Cited by 14
A novel strategy for designing the magic shotguns for distantly related target pairs
Luo, Y., Wang, P., Mou, M., Zheng, H., Hong, J., Tao, L., & Zhu, F. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac621 · Cited by 13
Activity Models of Key GPCR Families in the Central Nervous System: A Tool for Many Purposes
El-Atawneh, S., & Goldblum, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01531 · Cited by 15
Expanding potential targets of herbal chemicals by node2vec based on herb–drug interactions
Zhang, D., Cui, W.-Q., Hou, L., Yang, J., Lyu, L., Wang, Z.-Y., Linghu, K., He, W., Yu, H., & Yuanjia, H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00763-3 · Cited by 13
Effects of psychotropic drugs on brain plasticity in humans
Paulzen, M., Veselinović, T., & Gründer, G. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139004 · Cited by 14
Synthesis and evaluation of ligands for D2-like receptors: The role of common pharmacophoric groups
Sikazwe, D., Nkansah, N., Altundaş, R., Zhu, X. Y., Roth, B. L., Setola, V., & Ablordeppey, S. Y. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.054 · Cited by 13
Self-citationPlasmodium Drug Targets Outside the Genetic Control of the Parasite
Sullivan, D. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804070294 · Cited by 16
Johnsen, E., Hugdahl, K., Fusar‐Poli, P., Kroken, R. A., & Kompus, K. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.147 · Cited by 14
Davies, M. A., Conley, Y. P., & Roth, B. L. (2010) · Biological Research For Nursing · doi:10.1177/1099800409358760 · Cited by 17
Self-citationUsing Deep Learning for Compound Selectivity Prediction
Zhang, R., Li, J., Lu, J., Hu, R., Yuan, Y., & Zhao, Z. (2016) · Current Computer - Aided Drug Design · doi:10.2174/1573409912666160219113250 · Cited by 13
Phenotyping drug polypharmacology via eicosanoid profiling of blood
Song, J., Liu, X., Rao, T. S., Chang, L., Meehan, M. J., Blevitt, J. M., Wu, J., Dorrestein, P. C., & Milla, M. E. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058677 · Cited by 13
Rational design of multi-targeting ruthenium- and platinum-based anticancer complexes
Zheng, W., Zhao, Y., Luo, Q., Zhang, Y., Wu, K., & Wang, F. (2016) · Science China Chemistry · doi:10.1007/s11426-016-0178-7 · Cited by 13
Proteochemometric Modeling for Drug Repositioning
Schaduangrat, N., Anuwongcharoen, N., Phanus‐umporn, C., Sriwanichpoom, N., Wikberg, J. E. S., & Nantasenamat, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00010-9 · Cited by 13
Small-Scale Panel Comprising Diverse Gene Family Targets To Evaluate Compound Promiscuity
Sameshima, T., Yukawa, T., Hirozane, Y., Yoshikawa, M., Katoh, T., Hara, H., Yogo, T., Miyahisa, I., Okuda, T., Miyamoto, M., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00128 · Cited by 14
Small Molecule Effectors of Myosin Function
Manstein, D. J., & Preller, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38062-5_5 · Cited by 13
Interactions of Bioactive Plant Metabolites: Synergism, Antagonism, and Additivity
Boik, J. C., Kirakosyan, A., Kaufman, P. B., Seymour, E., & Spelman, K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0194-1_10 · Cited by 19
Onge, C. M. S., Pagare, P. P., Zheng, Y., Arriaga, M., Stevens, D. L., Mendez, R. E., Poklis, J. L., Halquist, M. S., Selley, D. E., Dewey, W. L., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00646 · Cited by 12
Chen, M., Zhao, N., Shi, W., Xing, Y., Liu, S., Meng, X., Li, L., Zhang, H., Meng, Y., Xie, S., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf005 · Cited by 17
‘Clean’ or ‘Dirty’ – Just How Selective do Drugs Need to Be?
Abbenante, G., Reid, R. C., & Fairlie, D. P. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08186 · Cited by 13
Gene activation therapy: from the BLV model to HAM/TSP patients
Lezin, A. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e20 · Cited by 12
Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty
Joshi, R., Quadros, R. M., Drumm, M., Ain, R., & Panicker, M. M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.007 · Cited by 14
A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers
Rao, S., Du, G., Hafner, M. A., Subramanian, K., Sorger, P. K., & Gray, N. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006805 · Cited by 15
Ågren, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-92204-0 · Cited by 15
Adeowo, F. Y., Oyetunji, T. P., Ejalonibu, M. A., Ndagi, U., Kumalo, H. M., & Lawal, M. M. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100361 · Cited by 12
Network‐Assisted Investigation of Antipsychotic Drugs and Their Targets
Sun, J., Xu, H., & Zhao, Z. (2012) · Chemistry & Biodiversity · doi:10.1002/cbdv.201100356 · Cited by 14
Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonists
Urbanek, R. A., Xiong, H., Wu, Y., Blackwell, W., Steelman, G. B., Rosamond, J., Wesolowski, S. S., Campbell, J. B., Zhang, M., Brockel, B. J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.023 · Cited by 12
Deane, F. M., Lin, A. J. S., Hains, P. G., Pilgrim, S. L., Robinson, P. J., & McCluskey, A. (2017) · ACS Omega · doi:10.1021/acsomega.7b00020 · Cited by 12
Bottemanne, H., Claret, A., & Fossati, P. (2020) · L Encéphale · doi:10.1016/j.encep.2020.08.006 · Cited by 15
Improving Translational Paradigms in Drug Discovery and Development
Williams, M. J. (2021) · Current Protocols · doi:10.1002/cpz1.273 · Cited by 12
Li, J., Li, X., Li, X., Yao, Y., Li, J. M., & Ma, K. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.108 · Cited by 13
Polypharmacological Drugs: “Magic Shotguns” for Psychiatric Diseases
Kroeze, W. K., & Roth, B. L. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch7 · Cited by 15
Self-citationRésimont, M., & Liégeois, J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.002 · Cited by 12
Identification and comparative analysis of G protein-coupled receptors in Pediculus humanus humanus
Li, C., Song, X., Chen, X., Liu, X., Sang, M., Wu, W., Yun, X., Hu, X., & Li, B. (2014) · Genomics · doi:10.1016/j.ygeno.2014.06.002 · Cited by 12
Vergara, S., Cardá, M., Agut, R., Yepes, L. M., Vélez, I. D., Robledo, S. M., & Galeano, W. C. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2019-2 · Cited by 12
Clozapine upregulates the expression of the vesicular GABA transporter (VGAT) in rat frontal cortex
Bragina, L., Melone, M., Fattorini, G., & Conti, F. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001987 · Cited by 15
Weinstein, J. J., Moeller, S. J., Perlman, G., Gil, R. B., Snellenberg, J. X. V., Wengler, K., Meng, J., Slifstein, M., & Abi‐Dargham, A. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.01.019 · Cited by 11
Vogt, I., Prinz, J., Worf, K., & Campillos, M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu487 · Cited by 11
Marques, A. M., Macena, M. V., Cardoso, A. R., Hammes, C. S. O., Pinheiro, F. M. L., Castro, N. G., & Neves, G. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05485-0 · Cited by 12
Whole proteome mapping of compound-protein interactions
Chirasani, V. R., Wang, J., Sha, C. M., Raup‐Konsavage, W. M., Vrana, K. E., & Dokholyan, N. V. (2022) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2022.100035 · Cited by 11
Is Rational Antipsychotic Polytherapy Feasible? A Selective Review
Kroken, R. A., & Johnsen, E. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0266-y · Cited by 11
Drug Repositioning: New Opportunities for Older Drugs
Poroikov, V., & Druzhilovskiy, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00001-8 · Cited by 12
Mallo‐Abreu, A., Reyes‐Resina, I., Azuaje, J., Franco, R., García-Rey, A., Majellaro, M., Miranda-Pastoriza, D., García-Mera, X., Jespers, W., Gutiérrez‐de‐Terán, H., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00704 · Cited by 11
Ribeiro, F. W. P., Mendonça, G. L. F., Soares, J. E. S., Freire, V. N., Souza, D. D., Casciano, P. N. S., de Lima‐Neto, P., & Correia, A. N. (2014) · Electrochimica Acta · doi:10.1016/j.electacta.2014.06.037 · Cited by 11
Zheng, C., Wu, Y.-S., Bao, H.-J., Xu, X., Chen, X.-Q., Ye, H., Wu, G., Xu, H., Li, X., Chen, J., et al. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1660 · Cited by 11
Overview of Drug Polypharmacology and Multitargeted Molecular Design
Chaudhari, R., Tan, Z., & Zhang, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12323-6 · Cited by 13
Promiscuous Anticancer Drugs from Pathogenic Bacteria: Rational Versus Intelligent Drug Design
Fialho, A. M., & Chakrabarty, A. M. (2010) · Wiley eBooks · doi:10.1002/9780470626528.ch8 · Cited by 11
Steroid-Induced Mania Treated with Aripiprazole
Kimmel, R. J., & Combs, H. L. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.03.002 · Cited by 11
Kucwaj‐Brysz, K., Kurczab, R., Żesławska, E., Lubelska, A., Marć, M. A., Latacz, G., Satała, G., Nitek, W., Kieć‐Kononowicz, K., & Handzlik, J. (2018) · MedChemComm · doi:10.1039/c8md00168e · Cited by 11
Xie, L., Kinnings, S., Xie, L., & Bourne, P. E. (2012) · Wiley eBooks · doi:10.1002/9781118274408.ch7 · Cited by 11
Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics
van den Brink, W. J., Hankemeier, T., van der Graaf, P. H., & de Lange, E. C. M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1446935 · Cited by 11
Abdolizadeh, A., Kupaei, M. H., Kambari, Y., Amaev, A., Korann, V., Torres‐Carmona, E., Song, J., Ueno, F., KOIZUMI, M., Nakajima, S., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.05.020 · Cited by 10
Ligand-directed trafficking of receptor stimulus
Chilmończyk, Z., Bojarski, A. J., & Sylte, I. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.06.006 · Cited by 11
Ivachtchenko, A. V., Frolov, E. B., Mitkin, O. D., Kysil, V. M., Khvat, A. V., & Tkachenko, S. E. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200900056 · Cited by 10
A Phenolic Antioxidant Releasing Nitric Oxide on Demand
Vittorino, E., & Sortino, S. (2009) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200901207 · Cited by 10
Jantschak, F., Brosda, J., Franke, R. T., Fink, H., Möller, D., Hübner, H., Gmeiner, P., & Pertz, H. H. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.205997 · Cited by 13
Selent, J., Bauer‐Mehren, A., López, L., Loza, M. I., Sanz, F., & Pastor, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060103 · Cited by 10
Dowarah, J., Marak, B. N., Lalhruaizela, L., Sran, B. S., & Singh, V. P. (2020) · Crystal Research and Technology · doi:10.1002/crat.202000100 · Cited by 10
In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
Sherif, M. A., Neymotin, S. A., & Lytton, W. W. (2020) · Schizophrenia · doi:10.1038/s41537-020-00109-0 · Cited by 11
Zagórska, A., Bucki, A., Partyka, A., Jastrzębska‐Więsek, M., Siwek, A., Głuch‐Lutwin, M., Mordyl, B., Jaromin, A., Walczak, M., Wesołowska, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114218 · Cited by 10
Lago, S. G., Tomasik, J., van Rees, G. F., Rustogi, N., Vázquez-Bourgón, J., Papiol, S., Suárez‐Pinilla, P., Crespo‐Facorro, B., & Bahn, S. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.016 · Cited by 10
Pharmacological MRI Approaches to Understanding Mechanisms of Drug Action
Minzenberg, M. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_177 · Cited by 10
Svenningsen, K., Venø, M. T., Henningsen, K., Mallien, A. S., Jensen, L., Christensen, T. T., Kjems, J., Vollmayr, B., & Wiborg, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160318 · Cited by 11
Okazaki, S., Noguchi‐Yachide, T., Sakai, T., Ishikawa, M., Makishima, M., Hashimoto, Y., & Yamaguchi, T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.045 · Cited by 10
Zagórska, A., Partyka, A., Bucki, A., Kołaczkowski, M., Jastrzębska‐Więsek, M., Czopek, A., Siwek, A., Głuch‐Lutwin, M., Bednarski, M., Bajda, M., et al. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13442 · Cited by 10
Harnessing the Therapeutic Potential of ‘Rogue’ Antibodies
Dimitrov, J. D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.03.005 · Cited by 13
N-Tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B
Kwon, Y. J., Saubern, S., Macdonald, J. M., Huang, X., Setola, V., & Roth, B. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.074 · Cited by 10
Self-citationDeveloping selectively nonselective drugs for treating CNS disorders
Gray, J. A., & Roth, B. L. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.009 · Cited by 11
Self-citationCarato, P., Graulich, A., Jensen, N., Roth, B. L., & Liégeois, J.-F. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.096 · Cited by 10
Self-citationAvchaciov, K., Clay, K. J., Denisov, K. A., Burmistrova, O., Petrascheck, M., & Fedichev, P. O. (2025) · Aging Cell · doi:10.1111/acel.70060 · Cited by 9
Drug Repositioning Strategies to Explore New Candidates Treating Prostate Cancer
Turanlı, B., & Arğa, K. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00027-4 · Cited by 9
Kim, Y., & Kim, S. (2023) · Psychiatry Investigation · doi:10.30773/pi.2022.0343 · Cited by 10
Drakakis, G., Wafford, K. A., Brewerton, S. C., Bodkin, M. J., Evans, D. A. P., & Bender, A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00209 · Cited by 10
Scott, T. J., & Vonortas, N. S. (2019) · The Journal of Technology Transfer · doi:10.1007/s10961-019-09743-y · Cited by 9
Cys-loop receptors on cannabinoids: All high?
Schmiedhofer, P. B., Vogel, F. D., Koniuszewski, F., & Ernst, M. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1044575 · Cited by 10
Vranic, M., Ahmed, F., Hetty, S., Sarsenbayeva, A., Ferreira, V., Fanni, G., Valverde, Á. M., Eriksson, J. W., & Pereira, M. J. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111828 · Cited by 9
Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia
Miljević, Č., Munjiza, A., & Jovanović, T. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s396168 · Cited by 11
Zhou, Z., Zhang, W., Zhao, F., Sun, Y., Wang, N., Cheng, J., Zhan, P., Yang, F., Sun, J., Liu, X., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00195 · Cited by 9
Chagas-Silva, F., Nascimento-Viana, J. B., Romeiro, L. A. S., Barberato, L. C., Noël, F., & Silva, C. L. M. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0935-3 · Cited by 9
Efficient and scalable synthesis of thiazole fused benzazepine as a D2 partial agonist
Xiong, H., Wu, Y., Lehr, S. G., Blackwell, W., Steelman, G. B., Hulsizer, J., & Urbanek, R. A. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.08.035 · Cited by 9
Enzensperger, C., Görnemann, T., Pertz, H. H., & Lehmann, J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.081 · Cited by 9
Pharmacology of "atypicality" of antipsychotic drugs: status and perspectives
Newman‐Tancredi, A., & Kleven, M. S. (2010) · Cited by 9
Exploring Polypharmacology in Drug Design
Méndez, P. S., & Eriksson, L. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8630-9_13 · Cited by 9
Conner, J., Poole, D. P., Jörg, M., & Veldhuis, N. A. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0327 · Cited by 9
Metadata
- Authors
- Roth, B. L., Sheffler, D. J., & Kroeze, W. K.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Roth, Bryan L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-04
- Volume
- 3
- Issue
- 4
- Pages
- 353-359
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2122995608
- Cited by
- 1,155
- References
- 63
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 37 · 2023: 39 · 2022: 47 · 2021: 49 · 2020: 49 · 2019: 63 · 2018: 46 · 2017: 42 · 2016: 61 · 2015: 65 · 2014: 58 · 2013: 73 · 2012: 83
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- magic bullet, polygenic disease, mood disorders, schizophrenia, depression, bipolar disorder, central nervous system disorders, drug target selectivity, polypharmacology, antipsychotic drug development
- MeSH terms
- Humans, Schizophrenia, Antipsychotic Agents, Drugs, Investigational, Comorbidity, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.